Anti-inflammatory and antiplatelet activities of plasma are conserved across twelve mammalian species

Molecules. 2014 Jul 31;19(8):11385-94. doi: 10.3390/molecules190811385.

Abstract

Human plasma inhibits arachidonic acid metabolism and platelet aggregation. This helps human form a haemostatic control system that prevents the progress of certain aggregatory or inflammatory reactions. Whether this property of plasma is unique to human or extends to other species is not well known. It is speculated that this protective ability of plasma remains evolutionarily conserved in different mammals. In order to confirm this, the effect of plasma from 12 different mammalian species was investigated for its inhibitory potential against arachidonic acid metabolism and platelet aggregation. Metabolism of arachidonic acid by cyclooxygenase and lipoxygenase pathways was studies using radio-immuno assay and thin layer chromatography while platelet aggregation in the plasma of various mammals was monitored following turbedmetric method in a dual channel aggregometer. Results indicate that inhibition of AA metabolism and platelet aggregation is a common feature of plasma obtained from different mammalian species, although there exists large interspecies variation. This shows that besides human, other mammals also possess general protective mechanisms against various aggregatory and inflammatory conditions and this anti-inflammatory property of the plasma is evolutionarily conserved in mammalian species. The most likely candidates responsible for these properties of plasma include haptoglobin, albumin and lipoproteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Arachidonic Acid / metabolism
  • Biological Evolution
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism
  • Cyclooxygenase Inhibitors / pharmacology
  • Hemostasis
  • Humans
  • Inhibitory Concentration 50
  • Lipoxygenase / metabolism
  • Lipoxygenase Inhibitors / pharmacology
  • Plasma* / metabolism
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / pharmacology*
  • Prostaglandin-Endoperoxide Synthases / metabolism

Substances

  • Anti-Inflammatory Agents
  • Cyclooxygenase Inhibitors
  • Lipoxygenase Inhibitors
  • Platelet Aggregation Inhibitors
  • Arachidonic Acid
  • Lipoxygenase
  • Prostaglandin-Endoperoxide Synthases